Research Topics
| Jonathan A McCullersSummaryAffiliation: St. Jude Children's Research Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulenceJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105 2794, USA
Virology 336:318-26. 2005..This observation suggests a role for the C domain of the M1 protein in growth and virulence in a mammalian host...
Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virusVictor C Huber
Department of Infectious Disease, St Jude Children s Research Hospital, 332 N Lauderdale Street, Memphis, TN 38105 2794, USA
Vaccine 26:5381-8. 2008..Our results differ from generally accepted influenza A virus vaccine models, and argue that strategies for control of influenza B virus should be considered separately from those for influenza A virus...
Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenzaAsa Karlström
Department of Infectious Diseases and the Veterinary Pathology Core, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
J Infect Dis 199:311-9. 2009..These data suggest that beta-lactam therapy may not be optimal as a first-line treatment for community-acquired pneumonia when it follows influenza...
The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenzaJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Scand J Infect Dis 40:11-7. 2008....
A multi-valent vaccine approach that elicits broad immunity within an influenza subtypeVictor C Huber
Department of Infectious Disease, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Vaccine 27:1192-200. 2009....
Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferretsJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee, USA
J Infect Dis 202:1287-95. 2010..Overall, these data argue that the relationship between respiratory viral infections, acquisition of pneumococci, and development of disease in humans needs further study to be better understood...
Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenzaJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
J Infect Dis 190:519-26. 2004....
Immunopathogenic and Antibacterial Effects of H3N2 Influenza A Virus PB1-F2 Map to Amino Acid Residues 62, 75, 79, and 82Irina V Alymova
Department of Infectious Diseases, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105 2794
J Virol 85:12324-33. 2011....
Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adultsHana Hakim
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN, United States
Vaccine 30:879-85. 2012..Influenza vaccination is recommended for immunocompromised patients...
Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoproteinIrina V Alymova
Department of Infectious Diseases, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105 3678, USA
Glycobiology 22:174-80. 2012..Binding to α2-3-linked SAs with a sulfated sialyl-Lewis motif as well as to α2-8-linked SAs was unique for the second binding site. Neither site recognizes α2-6-linked oligosaccharides...
Influenza virus primes mice for pneumonia from Staphylococcus aureusAmy R Iverson
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Infect Dis 203:880-8. 2011..The viral cytotoxin PB1-F2 contributed to the negative outcomes. These data suggest that additional study of specific bacterial virulence factors involved in the pathogenesis of inflammation and lung damage during coinfections is needed...
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumoniaJulie L McAuley
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Cell Host Microbe 2:240-9. 2007..These findings help explain both the unparalleled virulence of the 1918 strain and the high incidence of fatal pneumonia during the pandemic...
Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogensJenni N Weeks-Gorospe
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee, USA
J Virol 86:9035-43. 2012..These findings support efforts to increase influenza virus surveillance to consider viral genotypes that could be used to predict increased severity of superinfections with specific Gram-positive respiratory pathogens...
Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniaeJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
J Infect Dis 187:1000-9. 2003..Selective NA inhibitors may be useful clinically to interrupt this novel mechanism of synergism and to prevent excess mortality from secondary bacterial pneumonia...
Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniaeJonathan A McCullers
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
PLoS Pathog 3:e28. 2007
Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenzaVictor C Huber
Deparment of Infectious Disease, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
Clin Vaccine Immunol 13:981-90. 2006..This study details separate but important roles for both IgG1 and IgG2a expression in vaccination against influenza and argues for the development of vaccine regimens that stimulate and measure expression of both antibody isotypes...
Vaccines against pandemic influenza: what can be done before the next pandemic?Victor C Huber
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Pediatr Infect Dis J 27:S113-7. 2008..Thus, a prepandemic vaccine strategy that involves the stockpiling of both potential antigens and proven adjuvants may represent the best approach to deal with this looming threat...
Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancerSilvana Carr
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN, USA
J Infect Dis 204:1475-82. 2011..The safety and immunogenicity of live, attenuated influenza vaccine (LAIV) has not been compared to that of the standard trivalent inactivated vaccine (TIV) in children with cancer...
PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathologyJulie L McAuley
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee, United States of America
PLoS Pathog 6:e1001014. 2010..These data suggest that the PB1-F2 protein contributes to the virulence of pandemic strains when the PB1 gene segment is recently derived from the avian reservoir...
Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant miceGlendie Marcelin
Department of Infectious Diseases, Division of Virology, St Jude Children s Research Hospital, 262 Danny Thomas Place, Mail Stop 330, Memphis, TN 38105, USA
J Virol 85:11208-19. 2011..Therefore, immunopathology likely caused by elevated cellular recruitment is an implicated mechanism of severe pH1N1 infection in pregnant mice...
Bacterial sinusitis and otitis media following influenza virus infection in ferretsVille T Peltola
Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale St, Memphis, TN 38105-2794, USA
Infect Immun 74:2562-7. 2006..These data may partially explain why bacterial complication rates are higher during seasons when H3N2 viruses predominate. This animal model will be useful for further study of the mechanisms that underlie viral-bacterial synergism...
N-linked glycosylation attenuates H3N2 influenza virusesDavid J Vigerust
St Jude Children s Research Hospital, 332 N Lauderdale Street, Memphis, TN 38105 2794, USA
J Virol 81:8593-600. 2007..The continued exploration of interactions between highly glycosylated viruses and surfactant proteins may lead to an improved understanding of the biology within the lung and strategies for viral control...
Chloroquine is effective against influenza A virus in vitro but not in vivoDavid J Vigerust
Department of Infectious Diseases, St Jude Children s Research Hospital, 332 N Lauderdale Street, Memphis, TN 38105 2794, USA
Influenza Other Respi Viruses 1:189-92. 2007..Chloroquine is an inexpensive and widely available 9-aminoquinolone used in the management of malaria. Recently, in vitro assays suggest that chloroquine may have utility in the treatment of several viral infections including influenza...
Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenzaMatthew W Smith
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN, USA
Comp Med 57:82-9. 2007..Mortality correlated with the development of pneumonia and lung inflammation but not with bacteremia. This model has the potential to help us understand the pathogenesis of severe lung infections...
Correlates of vaccine protection from influenza and its complicationsJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN, USA
Hum Vaccin Immunother 8:34-44. 2012..Assessment of vaccine effectiveness for both viral and bacterial vaccines should include measures of impact on secondary bacterial pneumonia...
FluBlok, a recombinant influenza vaccineVictor C Huber
St Jude Children s Research Hospital, Department of Infectious Disease, Memphis, TN 38105, USA
Curr Opin Mol Ther 10:75-85. 2008..Phase III clinical trials to compare FluBlok and a licensed trivalent influenza vaccine for immunogenicity, safety and efficacy in preventing naturally occurring influenza are ongoing...
Improving therapeutic strategies for secondary bacterial pneumonia following influenzaJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, 332 N Lauderdale St, Memphis, TN 38105 2794, USA
Future Microbiol 3:397-404. 2008..In the not-so-distant future, strategies aimed at disarming pathogens without eliminating them may be more effective than our current treatment paradigms...
Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenzaAsa Karlström
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Infect Dis 204:1358-66. 2011..These data suggest that strategies for eliminating bacteria without lysis coupled with immunomodulation of inflammation should be pursued clinically...
No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodiesDavid J Wang
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Influenza Other Respi Viruses 6:159-66. 2012..Previously, influenza vaccination was linked with the increased incidence of GBS; however, whether antiganglioside antibodies are subsequently induced remains unresolved...
The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniaeIrina V Alymova
Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794, USA
Antimicrob Agents Chemother 49:398-405. 2005..Prophylaxis of parainfluenza virus infections with antivirals might be an effective strategy for prevention of secondary bacterial complications in humans...
The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesisJulie L McAuley
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Virol 84:558-64. 2010..Alternate mechanisms besides alterations to replication are likely responsible for the enhanced virulence in mammalian hosts attributed to PB1-F2 in previous studies...
Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virusJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Clin Infect Dis 50:1487-92. 2010..Receipt of a vaccine to a related virus significantly enhanced the neutralization capacity of these responses, suggesting homologous vaccination against the 2009 pandemic H1N1 influenza virus would have a similar effect...
Respiratory viruses predisposing to bacterial infections: role of neuraminidaseVille T Peltola
Department of Infectious Diseases, St Judes Children's Research Hospital, Memphis, TN, USA
Pediatr Infect Dis J 23:S87-97. 2004..Prevention of bacterial superinfection is likely to depend on effective antiviral measures...
Increased influenza vaccination of healthcare workers at a pediatric cancer hospital: results of a comprehensive influenza vaccination campaignJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Infect Control Hosp Epidemiol 27:77-9. 2006..A strategy of weekly feedback to unvaccinated employees was the most important factor in enhancing the rate of vaccination acceptance and was particularly effective among the nursing staff...
Influenza virus neuraminidase contributes to secondary bacterial pneumoniaVille T Peltola
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA
J Infect Dis 192:249-57. 2005..These data lend support to our hypothesis that the influenza virus neuraminidase contributes to secondary bacterial pneumonia and subsequent excess mortality...
Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in miceKeith Wanzeck
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Am J Respir Crit Care Med 183:767-73. 2011..Gain of glycans within antigenic sites of the HA during adaptation to the mammalian lung facilitates immune evasion...
Motivating factors for high rates of influenza vaccination among healthcare workersHana Hakim
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN, United States
Vaccine 29:5963-9. 2011..Factors associated with HCW uptake of influenza vaccines have not previously been evaluated in a high compliance rate setting...
WASP- mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCGSamita Andreansky
Department of Immunology, St Jude Children s Hospital, Memphis, TN 38104, USA
Exp Hematol 33:443-51. 2005..To quantify the immune response of WASP- mice to three different pathogens: influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis...
Seroprevalence of seasonal and pandemic influenza A viruses in domestic catsJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Arch Virol 156:117-20. 2011..Seroprevalance of seasonal H1N1 (41.9%) and H3N2 (25.6%) viruses was similarly high. These data reflecting past infection of household cats raise the possibility that they may act as a vector of influenza transmission within households...
Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferretsVictor C Huber
Department of Infectious Disease, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA
J Infect Dis 193:677-84. 2006..These findings support the potential use of this vaccine in immunocompromised humans...
Preparing for the next influenza pandemicJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Pediatr Infect Dis J 27:S57-9. 2008..Physicians and hospitals can begin by educating themselves on the problem and developing a pandemic plan for their own practice or organization...
Insights into the interaction between influenza virus and pneumococcusJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, 332 N Lauderdale St, Memphis, TN 38105 2794, USA
Clin Microbiol Rev 19:571-82. 2006..Identification and exploration of the underlying mechanisms responsible for this synergism will provide targets for prevention and treatment using drugs and vaccines...
Antiviral therapy of influenzaJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105 2794, USA
Expert Opin Investig Drugs 14:305-12. 2005..This review presents the current status of antiviral therapy of, and highlights the challenges presented by, the threat of pandemic influenza...
Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumoniaJenni N Weeks
Department of Infectious Diseases, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Antimicrob Agents Chemother 55:2276-81. 2011..Antibody-based therapies, when coupled with immune modulators, such as P4 peptide, may be an effective tool together with antibiotics in our armamentarium against severe pneumonia...
Preventing and treating secondary bacterial infections with antiviral agentsJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN, USA
Antivir Ther 16:123-35. 2011..By applying these insights to antiviral drug development, the potential exists to improve outcomes by means other than direct inhibition of the virus...
Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitisSteven C Buckingham
Department of Pediatrics, University of Tennessee Health Science Center, Le Bonheur Children s Medical Center, Memphis, Tennessee, USA
Pediatrics 117:1688-94. 2006..The relationship between timing of the first dose of vancomycin relative to other antibiotics and outcome in these children, however, has not been addressed...
Levels of total fungus and Aspergillus on a pediatric hematopoietic stem cell transplant unitMary Elizabeth Hensley
St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
J Pediatr Oncol Nurs 21:67-78. 2004..t tests and analysis of variance were used to verify the findings...
Multiple genotypes of influenza B virus circulated between 1979 and 2003Jonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, 332 N Lauderdale St, Memphis, TN 38105 2794, USA
J Virol 78:12817-28. 2004....
A practical guide to alcohol-based hand hygiene infrastructure in a resource-poor pediatric hospitalMiguela A Caniza
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 3678, USA
Am J Infect Control 37:851-4. 2009..Alcohol-based HH can compensate for inadequate infrastructure and supplies. We describe the implementation of alcohol-based HH in five high-risk wards of a pediatric hospital in El Salvador...
Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptorJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
J Infect Dis 186:341-50. 2002..The model of lethal synergism will be a useful tool for exploring this and other mechanisms underlying viral-bacterial interactions...
Evolution, benefits, and shortcomings of vaccine managementJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
J Manag Care Pharm 13:S2-6. 2007..However, many targets for immunization remain uncontrolled, and new or improved vaccines are emerging to meet these challenges...
Are toilet seats a vector for transmission of methicillin-resistant Staphylococcus aureus?Mary Anne Giannini
Infection Control Program, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Am J Infect Control 37:505-6. 2009..Methicillin-resistant Staphylococcus aureus (MRSA) was recovered from 3.3% of hospital toilets when wipes were not in use. Use of wipes resulted in a 50-fold reduction in mean daily bacterial counts and eliminated MRSA...
The clinical need for new antiviral drugs directed against influenza virusJonathan A McCullers
J Infect Dis 193:751-3. 2006
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infectionAbiodun D Ogunniyi
School of Molecular and Biomedical Science, University of Adelaide, South Australia 5005, Australia
Vaccine 26:4676-85. 2008..We propose that c-di-GMP can be used as an effective broad spectrum immunomodulator and vaccine adjuvant to prevent infectious diseases...
Planning for an influenza pandemic: thinking beyond the virusJonathan A McCullers
J Infect Dis 198:945-7. 2008
A step closer to meeting the threat of avian influenzaStacey Schultz-Cherry
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
PLoS Med 3:e375. 2006
